NM_030662.4:c.856G>C

Variant summary

Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4

The NM_030662.4(MAP2K2):​c.856G>C​(p.Gly286Arg) variant causes a missense change. The variant allele was found at a frequency of 0.00000206 in 1,453,258 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another nucleotide change resulting in the same amino acid substitution has been previously reported as Uncertain significance in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G286E) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000021 ( 0 hom. )

Consequence

MAP2K2
NM_030662.4 missense

Scores

1
3
14

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 4.04

Publications

4 publications found
Variant links:
Genes affected
MAP2K2 (HGNC:6842): (mitogen-activated protein kinase kinase 2) The protein encoded by this gene is a dual specificity protein kinase that belongs to the MAP kinase kinase family. This kinase is known to play a critical role in mitogen growth factor signal transduction. It phosphorylates and thus activates MAPK1/ERK2 and MAPK2/ERK3. The activation of this kinase itself is dependent on the Ser/Thr phosphorylation by MAP kinase kinase kinases. Mutations in this gene cause cardiofaciocutaneous syndrome (CFC syndrome), a disease characterized by heart defects, cognitive disability, and distinctive facial features similar to those found in Noonan syndrome. The inhibition or degradation of this kinase is also found to be involved in the pathogenesis of Yersinia and anthrax. A pseudogene, which is located on chromosome 7, has been identified for this gene. [provided by RefSeq, Jul 2008]
MAP2K2 Gene-Disease associations (from GenCC):
  • cardiofaciocutaneous syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • cardiofaciocutaneous syndrome 4
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • neurofibromatosis-Noonan syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Noonan syndrome
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.4206183).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_030662.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MAP2K2
NM_030662.4
MANE Select
c.856G>Cp.Gly286Arg
missense
Exon 7 of 11NP_109587.1
MAP2K2
NM_001440689.1
c.286G>Cp.Gly96Arg
missense
Exon 5 of 9NP_001427618.1
MAP2K2
NM_001440688.1
c.705+1755G>C
intron
N/ANP_001427617.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MAP2K2
ENST00000262948.10
TSL:1 MANE Select
c.856G>Cp.Gly286Arg
missense
Exon 7 of 11ENSP00000262948.4
MAP2K2
ENST00000945862.1
c.856G>Cp.Gly286Arg
missense
Exon 7 of 11ENSP00000615921.1
MAP2K2
ENST00000897166.1
c.856G>Cp.Gly286Arg
missense
Exon 7 of 11ENSP00000567225.1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD2 exomes
AF:
0.00000432
AC:
1
AN:
231538
AF XY:
0.00000792
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000971
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000206
AC:
3
AN:
1453258
Hom.:
0
Cov.:
33
AF XY:
0.00000415
AC XY:
3
AN XY:
722386
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33334
American (AMR)
AF:
0.00
AC:
0
AN:
43610
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25932
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39322
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85090
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51534
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5754
European-Non Finnish (NFE)
AF:
0.00000271
AC:
3
AN:
1108632
Other (OTH)
AF:
0.00
AC:
0
AN:
60050
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
33
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000113
ExAC
AF:
0.00000827
AC:
1

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.093
BayesDel_addAF
Uncertain
0.057
T
BayesDel_noAF
Benign
-0.16
CADD
Benign
19
DANN
Benign
0.86
DEOGEN2
Benign
0.15
T
Eigen
Benign
-0.65
Eigen_PC
Benign
-0.57
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Benign
0.76
T
M_CAP
Uncertain
0.087
D
MetaRNN
Benign
0.42
T
MetaSVM
Benign
-0.41
T
MutationAssessor
Benign
1.4
L
PhyloP100
4.0
PrimateAI
Benign
0.48
T
PROVEAN
Benign
-0.81
N
REVEL
Uncertain
0.31
Sift
Benign
0.28
T
Sift4G
Benign
0.49
T
Polyphen
0.0
B
Vest4
0.60
MutPred
0.38
Loss of catalytic residue at P282 (P = 0.0711)
MVP
0.77
MPC
0.53
ClinPred
0.15
T
GERP RS
3.4
Varity_R
0.053
gMVP
0.74
Mutation Taster
=54/46
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs730880523; hg19: chr19-4099262; API